Clinical Trial Results:
Etude de la tolérance et de l'efficacité du Zevalin dans un conditionnement à intensité réduite avant allogreffe de cellules souches hématopoïétiques dans les lymphomes B CD20+ agressifs de l'adulte, en rechute sensible : étude de phase II
Summary
|
|
EudraCT number |
2007-003821-25 |
Trial protocol |
FR |
Global completion date |
08 Nov 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Apr 2025
|
First version publication date |
13 Apr 2025
|
Other versions |
|
Summary report(s) |
EudraCT 2007-003821-25 article ZEVALLO trial |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.